Abdominal aortic aneurysm(AAA) is a common and potentially dangerous vascular disease with many risk factors related to its occurrence and development. This review collects the results from recent studies of different...Abdominal aortic aneurysm(AAA) is a common and potentially dangerous vascular disease with many risk factors related to its occurrence and development. This review collects the results from recent studies of different comorbidities including hypertension, diabetes, and hyperlipidemia and summarizes their connections with AAA development and its underlying mechanisms. We believe that hypertension, diabetes, and hyperlipidemia can affect AAA occurrence and development, but more studies are needed to further explore the mechanisms.展开更多
Aortic dissection is a life-threatening condition for which diagnosis mainly relies on imaging examinations,while reliable biomarkers to detect or monitor are still under investigation.Recent advances in technologies ...Aortic dissection is a life-threatening condition for which diagnosis mainly relies on imaging examinations,while reliable biomarkers to detect or monitor are still under investigation.Recent advances in technologies provide an unprecedented opportunity to yield the identification of clinically valuable biomarkers,including proteins,ribonucleic acids(RNAs),and deoxyribonucleic acids(DNAs),for early detection of pathological changes in susceptible patients,rapid diagnosis at the bedside after onset,and a superior therapeutic regimen primarily within the concept of personalized and tailored endovascular therapy for aortic dissection.展开更多
Muscle necrosis and angiogenesis are two major challenges in the treatment of lower-limb ischemic diseases.In this study,a triple-functional Sr/Si-containing bioceramic/alginate composite hydrogel with simultaneous bi...Muscle necrosis and angiogenesis are two major challenges in the treatment of lower-limb ischemic diseases.In this study,a triple-functional Sr/Si-containing bioceramic/alginate composite hydrogel with simultaneous bioactivity in enhancing angiogenesis,regulating inflammation,and inhibiting muscle necrosis was designed to treat lower-limb ischemic diseases.In particular,sodium alginate,calcium silicate and strontium carbonate were used to prepare injectable hydrogels,which was gelled within 10 min.More importantly,this composite hydrogel sustainedly releases bioactive Sr^(2+)and SiO_(3)^(2-) ions within 28 days.The biological activity of the bioactive ions released from the hydrogels was verified on HUVECs,SMCs,C2C12 and Raw 264.7 cells in vitro,and the therapeutic effect of the hydrogel was confirmed using C57BL/6 mouse model of femoral artery ligation in vivo.The results showed that the composite hydrogel stimulated angiogenesis,developed new collateral capillaries,and re-established the blood supply.In addition,the bioactive hydrogel directly promoted the expression of muscle-regulating factors(MyoG and MyoD)to protect skeletal muscle from necrosis,inhibited M1 polarization,and promoted M2 polarization of macrophages to reduce inflammation,thereby protecting skeletal muscle cells and indirectly promoting vascularization.Our results indicate that these bioceramic/alginate composite bioactive hydrogels are effective biomaterials for treating hindlimb ischemia and suggest that biomaterial-based approaches may have remarkable potential in treating ischemic diseases.展开更多
The efficacy of stem cell therapy is substantially compromised due to low cell survival rate and poor local retention post-delivery. These issues drastically limit the application of stem cells for ischemic limb thera...The efficacy of stem cell therapy is substantially compromised due to low cell survival rate and poor local retention post-delivery. These issues drastically limit the application of stem cells for ischemic limb therapy, which requires effective blood perfusion and skeletal muscle regeneration. Herein, based on microfluidic technology, an integrated stem cell and cytokine co-delivery system designed for functional ischemic limb salvage was constructed by first incorporating the myogenic cytokine, fibroblast growth factor 19 (FGF19), into microspheres composed of methacrylate gelatin (GelMA). Then adipose-derived stem cells (ADSCs) were highly absorbed into the porous structure of the microspheres, overcoming the insufficient loading efficiency and activities by conventional encapsulation strategy. The fabricated ADSCs/FGF19@μsphere system demonstrated a uniform size of about 180 μm and a highly porous structure with pore sizes between 20 and 40 μm. The resultant system allowed high doses of ADSCs to be precisely engrafted in the lesion and to survive, and achieved sustained FGF19 release in the ischemic region to facilitate myoblast recruitment and differentiation and myofibrils growth. Furthermore, the combination of ADSCs and FGF19 exhibited a positive synergistic effect which substantially improved the therapeutic benefit of angiogenesis and myogenesis, both in vitro and in vivo. In summary, a stem cell and cytokine co-delivery system with the properties of easy preparation and minimal invasiveness was designed to ensure highly efficient cell delivery, sustained cytokine release, and ultimately realizes effective treatment of ischemic limb regeneration.展开更多
To the Editor:Iliac vein compression syndrome(IVCS)is a well-documented anatomic abnormality characterized by the compression of iliac veins from the adjacent artery and vertebra.Depending on whether deep vein thrombo...To the Editor:Iliac vein compression syndrome(IVCS)is a well-documented anatomic abnormality characterized by the compression of iliac veins from the adjacent artery and vertebra.Depending on whether deep vein thrombosis was co-existing,IVCS could be classified into thrombotic and nonthrombotic lesions.Endovascular procedures have become the mainstream treatment for nonthrombotic IVCS.[1]In most cases.展开更多
To the Editor:Ruptured abdominal aortic aneurysm(rAAA)is a fatal disease.Emergency surgery is the only way to provide an opportunity for survival.In 1994,endovascular aortic repair(EVAR)was reported as an emergency tr...To the Editor:Ruptured abdominal aortic aneurysm(rAAA)is a fatal disease.Emergency surgery is the only way to provide an opportunity for survival.In 1994,endovascular aortic repair(EVAR)was reported as an emergency treatment for rAAA.Compared with traditional open surgery(OS),patients could benefit from its lower perioperative mortality and minimal invasiveness.Although recent guidelines have recommended an EVARfirst approach if suitable as judged by the clinician,the standard of whether to give a priority to EVAR varies among clinicians in practical applications,because hostile aortic morphology and hemodynamic conditions were thought to weaken the benefit of EVAR.Hence,controversies still exist regarding whether EVAR as a priority is applicable to most rAAAs.In addition,a search of the literature found few population-based studies with long-term outcomes.Given this,a population-based study was conducted by Zhongshan Hospital,Fudan University.展开更多
It is known that the Proximal Extension To Induce Complete Attachment(PETTICOAT)technique improves the distal aortic remodeling compared with standard thoracic endovascular aortic repair(TEVAR).[1,2]However,the only a...It is known that the Proximal Extension To Induce Complete Attachment(PETTICOAT)technique improves the distal aortic remodeling compared with standard thoracic endovascular aortic repair(TEVAR).[1,2]However,the only available Zenith Dissection Endovascular System(Cook Medical Inc.,Bloomington,Ind,USA)has several limitations,including only two sizes(36 mm and 46 mm)and an one-taper design,which may not be suitable for the complex morphology of dissection at distal aorta,particular for the east Asian population.Thus,our center designed the new“Fabulous”stent system and acheieved better early curative effect.展开更多
With high rates of morbidity and mortality,posterior circulation stroke accounts for 20% of ischemic strokes,and approximately 25% occurs in patients with stenosis in the vertebral and/or basilar arteries.liiOn the ot...With high rates of morbidity and mortality,posterior circulation stroke accounts for 20% of ischemic strokes,and approximately 25% occurs in patients with stenosis in the vertebral and/or basilar arteries.liiOn the other hand,the risk of posterior circulation ischemic stroke reaches 30% in patients with symptomatic vertebral artery(VA)stenosis afterSyears,[2]subclavian artery(SA)occlusion,although with a low prevalence in the general population,is also an important causeof posterior circulation stroke.展开更多
文摘Abdominal aortic aneurysm(AAA) is a common and potentially dangerous vascular disease with many risk factors related to its occurrence and development. This review collects the results from recent studies of different comorbidities including hypertension, diabetes, and hyperlipidemia and summarizes their connections with AAA development and its underlying mechanisms. We believe that hypertension, diabetes, and hyperlipidemia can affect AAA occurrence and development, but more studies are needed to further explore the mechanisms.
基金supported by grants from the National Natural Science Foundation of China(No.81970412)the Science and Technology Innovation Plan of the Shanghai Science and Technology Commission(No.18441902400)
文摘Aortic dissection is a life-threatening condition for which diagnosis mainly relies on imaging examinations,while reliable biomarkers to detect or monitor are still under investigation.Recent advances in technologies provide an unprecedented opportunity to yield the identification of clinically valuable biomarkers,including proteins,ribonucleic acids(RNAs),and deoxyribonucleic acids(DNAs),for early detection of pathological changes in susceptible patients,rapid diagnosis at the bedside after onset,and a superior therapeutic regimen primarily within the concept of personalized and tailored endovascular therapy for aortic dissection.
基金supported by the National Natural Science Foundation of China(grant number:82270415)Key Project Fund of Natural Science Foundation of Fujian Science and Technology Department(grant number:2021GGB030)+8 种基金Shanghai Municipal Science and Technology Commission Innovation Fund(grant number:22S31904800)Fudan Zhangjiang Clinical Medicine Innovation Fund(grant number:KP7202115)Fujian Province Health Science and Technology Fund(grant number:2021GGB030)the National Natural Science Foundation of China(grant number:81970412)Medical-Industrial Cooperation Project of Zhongshan Hospital Affiliated to Fudan University(grant number:MP2021Q2C018)National Clinical Research Center for Interventional Medicine Fund(grant number:2021-004)Xiamen Municipal Health Science And Technology Program Fund(grant number:3502Z20194034)Zhongshan hospital’s Talents Supporting Plan(grant number:2019ZSGG11)Shanghai Municipal Science and Technology Commission Innovation Fund(grant number:18441902400).
文摘Muscle necrosis and angiogenesis are two major challenges in the treatment of lower-limb ischemic diseases.In this study,a triple-functional Sr/Si-containing bioceramic/alginate composite hydrogel with simultaneous bioactivity in enhancing angiogenesis,regulating inflammation,and inhibiting muscle necrosis was designed to treat lower-limb ischemic diseases.In particular,sodium alginate,calcium silicate and strontium carbonate were used to prepare injectable hydrogels,which was gelled within 10 min.More importantly,this composite hydrogel sustainedly releases bioactive Sr^(2+)and SiO_(3)^(2-) ions within 28 days.The biological activity of the bioactive ions released from the hydrogels was verified on HUVECs,SMCs,C2C12 and Raw 264.7 cells in vitro,and the therapeutic effect of the hydrogel was confirmed using C57BL/6 mouse model of femoral artery ligation in vivo.The results showed that the composite hydrogel stimulated angiogenesis,developed new collateral capillaries,and re-established the blood supply.In addition,the bioactive hydrogel directly promoted the expression of muscle-regulating factors(MyoG and MyoD)to protect skeletal muscle from necrosis,inhibited M1 polarization,and promoted M2 polarization of macrophages to reduce inflammation,thereby protecting skeletal muscle cells and indirectly promoting vascularization.Our results indicate that these bioceramic/alginate composite bioactive hydrogels are effective biomaterials for treating hindlimb ischemia and suggest that biomaterial-based approaches may have remarkable potential in treating ischemic diseases.
基金supported by the National Natural Science Foundation of China(grant number 8207021027)Shanghai Clinical Research Center for Interventional Medicine(grant number 19MC1910300)Shanghai Science and Technology Commission(grant numbers 19441906600,21S31904800).
文摘The efficacy of stem cell therapy is substantially compromised due to low cell survival rate and poor local retention post-delivery. These issues drastically limit the application of stem cells for ischemic limb therapy, which requires effective blood perfusion and skeletal muscle regeneration. Herein, based on microfluidic technology, an integrated stem cell and cytokine co-delivery system designed for functional ischemic limb salvage was constructed by first incorporating the myogenic cytokine, fibroblast growth factor 19 (FGF19), into microspheres composed of methacrylate gelatin (GelMA). Then adipose-derived stem cells (ADSCs) were highly absorbed into the porous structure of the microspheres, overcoming the insufficient loading efficiency and activities by conventional encapsulation strategy. The fabricated ADSCs/FGF19@μsphere system demonstrated a uniform size of about 180 μm and a highly porous structure with pore sizes between 20 and 40 μm. The resultant system allowed high doses of ADSCs to be precisely engrafted in the lesion and to survive, and achieved sustained FGF19 release in the ischemic region to facilitate myoblast recruitment and differentiation and myofibrils growth. Furthermore, the combination of ADSCs and FGF19 exhibited a positive synergistic effect which substantially improved the therapeutic benefit of angiogenesis and myogenesis, both in vitro and in vivo. In summary, a stem cell and cytokine co-delivery system with the properties of easy preparation and minimal invasiveness was designed to ensure highly efficient cell delivery, sustained cytokine release, and ultimately realizes effective treatment of ischemic limb regeneration.
文摘To the Editor:Iliac vein compression syndrome(IVCS)is a well-documented anatomic abnormality characterized by the compression of iliac veins from the adjacent artery and vertebra.Depending on whether deep vein thrombosis was co-existing,IVCS could be classified into thrombotic and nonthrombotic lesions.Endovascular procedures have become the mainstream treatment for nonthrombotic IVCS.[1]In most cases.
基金National Natural Science Foundation of China(No.8207021027)Shanghai Clinical Research Center for Interventional Medicine(No.19MC1910300)Shanghai Science and Technology Commission(Nos.19441906600 and 21S31904800)
文摘To the Editor:Ruptured abdominal aortic aneurysm(rAAA)is a fatal disease.Emergency surgery is the only way to provide an opportunity for survival.In 1994,endovascular aortic repair(EVAR)was reported as an emergency treatment for rAAA.Compared with traditional open surgery(OS),patients could benefit from its lower perioperative mortality and minimal invasiveness.Although recent guidelines have recommended an EVARfirst approach if suitable as judged by the clinician,the standard of whether to give a priority to EVAR varies among clinicians in practical applications,because hostile aortic morphology and hemodynamic conditions were thought to weaken the benefit of EVAR.Hence,controversies still exist regarding whether EVAR as a priority is applicable to most rAAAs.In addition,a search of the literature found few population-based studies with long-term outcomes.Given this,a population-based study was conducted by Zhongshan Hospital,Fudan University.
基金National Science Foundation of China(No.81970412)Shanghai Municipal Science and Technology Commission Innovation Fund(No.22S31904800)+5 种基金Fujian Province Health Science and Technology Fund(No.2021GGB030)Shanghai Municipal Science and Technology Commission Innovation Fund(No.18441902400)National Clinical Research Center for Interventional Medicine Fund(No.2021-004)Shanghai Municipal Health Commission(No.20214Y0474)Xiamen Municipal Health Science And Technology Program Fund(No.3502Z20194034)Fudan Zhangjiang Clinical Medicine Innovation Fund(No.KP7202115)
文摘It is known that the Proximal Extension To Induce Complete Attachment(PETTICOAT)technique improves the distal aortic remodeling compared with standard thoracic endovascular aortic repair(TEVAR).[1,2]However,the only available Zenith Dissection Endovascular System(Cook Medical Inc.,Bloomington,Ind,USA)has several limitations,including only two sizes(36 mm and 46 mm)and an one-taper design,which may not be suitable for the complex morphology of dissection at distal aorta,particular for the east Asian population.Thus,our center designed the new“Fabulous”stent system and acheieved better early curative effect.
基金supported by National Natural Science Foundation of China(32171509,32071905,32071521,32001087)the Natural Science Foundation of Jiangsu(BK20211321)+2 种基金Jiangsu Planned Projects for Postdoctoral Research Funds(2021K160B)Jiangsu University Research Foundation(20JDG055)Part of the funding for this research was supported by Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD).
基金This study was supported by grants from the China National Natural Science Funds(Grant No.81970407)Shanghai Excellent Academic Leader(No.19XD1401200).
文摘With high rates of morbidity and mortality,posterior circulation stroke accounts for 20% of ischemic strokes,and approximately 25% occurs in patients with stenosis in the vertebral and/or basilar arteries.liiOn the other hand,the risk of posterior circulation ischemic stroke reaches 30% in patients with symptomatic vertebral artery(VA)stenosis afterSyears,[2]subclavian artery(SA)occlusion,although with a low prevalence in the general population,is also an important causeof posterior circulation stroke.